Regulation of brain drug metabolizing enzymes and transporters by nuclear receptors

References

• Altinoz MA, Ozpinar A, Elmaci I. 2018. Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma. Neurosurg Rev. DOI:10.1007/s10143-018-0953-1
   PubMed Web of Science ®Google Scholar
• Anakk S, Kalsotra A, Kikuta Y, Huang W, Zhang J, Staudinger JL, Moore DD, Strobel HW. 2004. CAR/PXR provide directives for Cyp3a41 gene regulation differently from Cyp3a11. Pharmacogenomics J. 4:91–101.
   PubMed Web of Science ®Google Scholar
• Asai Y, Sakakibara Y, Nadai M, Katoh M. 2017. Effect of carbamazepine on expression of UDP-glucuronosyltransferase 1A6 and 1A7 in rat brain. Drug Metab Pharmacokinet. 32:286–292.
   PubMed Web of Science ®Google Scholar
• Asai Y, Tanaka H, Nadai M, Katoh M. 2018. Status epilepticus decreases brain cytochrome P450 2D4 expression in rats. J Pharm Sci. 107:975–978.
   PubMed Web of Science ®Google Scholar
• Ashraf T, Kis O, Banerjee N, Bendayan R. 2012. Drug transporters at brain barriers: expression and regulation by neurological disorders. Adv Exp Med Biol. 763:20–69.
   PubMed Web of Science ®Google Scholar
• Badders NM, Korff A, Miranda HC, Vuppala PK, Smith RB, Winborn BJ, Quemin ER, Sopher BL, Dearman J, Messing J, et al. 2018. Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy. Nat Med. 24:427–437.
   PubMed Web of Science ®Google Scholar
• Bauer B, Hartz AM, Fricker G, Miller DS. 2004. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol. 66:413–419.
   PubMed Web of Science ®Google Scholar
• Bauer B, Hartz AM, Lucking JR, Yang X, Pollack GM, Miller DS. 2008. Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier. J Cereb Blood Flow Metab. 28:1222–1234.
   PubMed Web of Science ®Google Scholar
• Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, Muscat G, Perlmann T, Renaud JP, Schwabe J, Sladek F, et al. 2006. International Union of Pharmacology. LXVI. Orphan nuclear receptors. Pharmacol Rev. 58:798–836.
   PubMed Web of Science ®Google Scholar
• Bing Y, Zhu S, Jiang K, Dong G, Li J, Yang Z, Yang J, Yue J. 2014. Reduction of thyroid hormones triggers down-regulation of hepatic CYP2B through nuclear receptors CAR and TR in a rat model of acute stroke. Biochem Pharmacol. 87:636–649.
   PubMed Web of Science ®Google Scholar
• Cai Y, Tang X, Chen X, Li X, Wang Y, Bao X, Wang L, Sun D, Zhao J, Xing Y, et al. 2018. Liver X receptor β regulates the development of the dentate gyrus and autistic-like behavior in the mouse . Proc Natl Acad Sci USA. 115:E2725–E2733.
   PubMed Web of Science ®Google Scholar
• Cao G, Bales KR, DeMattos RB, Paul SM. 2007. Liver X receptor-mediated gene regulation and cholesterol homeostasis in brain: relevance to Alzheimer's disease therapeutics. CAR. 4:179–184.
   Web of Science ®Google Scholar
• Cartagena CM, Ahmed F, Burns MP, Pajoohesh-Ganji A, Pak DT, Faden AI, Rebeck GW. 2008. Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain. J Neurotrauma. 25:1087–1098.
   PubMed Web of Science ®Google Scholar
• Castro-Caldas M, Neves Carvalho A, Peixeiro I, Rodrigues E, Lechner MC, Gama MJ. 2009. GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum. J Mol Neurosci. 38:114–127.
   PubMed Web of Science ®Google Scholar
• Chan GN, Hoque MT, Bendayan R. 2013. Role of nuclear receptors in the regulation of drug transporters in the brain. Trends Pharmacol Sci. 34:361–372.
   PubMed Web of Science ®Google Scholar
• Du ZH, Xia J, Sun XC, Li XN, Zhang C, Zhao HS, Zhu SY, Li JL. 2017. A novel nuclear xenobiotic receptors (AhR/PXR/CAR)-mediated mechanism of DEHP-induced cerebellar toxicity in quails (Coturnix japonica) via disrupting CYP enzyme system homeostasis. Environ Pollut. 226:435–443.
   PubMed Web of Science ®Google Scholar
• Dutheil F, Dauchy S, Diry M, Sazdovitch V, Cloarec O, Mellottee L, Bieche I, Ingelman-Sundberg M, Flinois JP, de Waziers I, et al. 2009. Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos. 37:1528–1538.
   PubMed Web of Science ®Google Scholar
• ElAli A, Hermann DM. 2012. Liver X receptor activation enhances blood-brain barrier integrity in the ischemic brain and increases the abundance of ATP-binding cassette transporters ABCB1 and ABCC1 on brain capillary cells. Brain Pathol. 22:175–187.
   PubMed Web of Science ®Google Scholar
• Eyal S, Hsiao P, Unadkat JD. 2009. Drug interactions at the blood-brain barrier: fact or fantasy? Pharmacol Ther. 123:80–104.
   PubMed Web of Science ®Google Scholar
• Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, De Lera AR, Lotan R, Mangelsdorf DJ, Gronemeyer H. 2006. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev. 58:712–725.
   PubMed Web of Science ®Google Scholar
• Germain P, Staels B, Dacquet C, Spedding M, Laudet V. 2006. Overview of nomenclature of nuclear receptors. Pharmacol Rev. 58:685–704.
   PubMed Web of Science ®Google Scholar
• Ghosh C, Hossain M, Solanki J, Najm IM, Marchi N, Janigro D. 2017. Overexpression of pregnane X and glucocorticoid receptors and the regulation of cytochrome P450 in human epileptic brain endothelial cells. Epilepsia. 58:576–585.
   PubMed Web of Science ®Google Scholar
• Gkikas D, Tsampoula M, Politis PK. 2017. Nuclear receptors in neural stem/progenitor cell homeostasis. Cell Mol Life Sci. 74:4097–4120.
   PubMed Web of Science ®Google Scholar
• Gupta S, Guha P, Majumder S, Pal P, Sen K, Chowdhury P, Chakraborty A, Panigrahi AK, Mukherjee D. 2018. Effects of bisphenol A (BPA) on brain-specific expression of cyp19a1b gene in swim-up fry of Labeo rohita. Comp Biochem Physiol C Toxicol Pharmacol. 209:63–71.
   PubMed Web of Science ®Google Scholar
• Harder L, Dudazy-Gralla S, Muller-Fielitz H, Hjerling Leffler J, Vennstrom B, Heuer H, Mittag J. 2018. Maternal thyroid hormone is required for parvalbumin neurone development in the anterior hypothalamic area. J Neuroendocrinol. 30:e12573.
   PubMed Web of Science ®Google Scholar
• Hoque MT, Shah A, More V, Miller DS, Bendayan R. 2015. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier. J Neurochem. 135:1113–1122.
   PubMed Web of Science ®Google Scholar
• Kort A, van Hoppe S, Sparidans RW, Wagenaar E, Beijnen JH, Schinkel AH. 2017. Brain accumulation of Ponatinib and its active metabolite, N-Desmethyl Ponatinib, is limited by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2). Mol Pharm. 14:3258–3268.
   PubMed Web of Science ®Google Scholar
• Krezel W, Kastner P, Chambon P. 1999. Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience. 89:1291–1300.
   PubMed Web of Science ®Google Scholar
• Kusuhara H, Sugiyama Y. 2005. Active efflux across the blood-brain barrier: role of the solute carrier family. NeuroRx. 2:73–85.
   PubMedGoogle Scholar
• Li HY, Liu F, Wang HR. 2018. Correlation between Nurr1 expression and drug resistance in the brain of rats with epilepsy. Eur Rev Med Pharmacol Sci. 22:1506–1513.
   PubMed Web of Science ®Google Scholar
• Lombardo L, Pellitteri R, Balazy M, Cardile V. 2008. Induction of nuclear receptors and drug resistance in the brain microvascular endothelial cells treated with antiepileptic drugs. Curr Neurovasc Res. 5:82–92.
   PubMed Web of Science ®Google Scholar
• Maden M. 2007. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci. 8:755–765.
   PubMed Web of Science ®Google Scholar
• Marino M, di Masi A, Trezza V, Pallottini V, Polticelli F, Ascenzi P. 2011. Xenosensors CAR and PXR at work: impact on statin metabolism. Curr Drug Metab. 12:300–311.
   PubMed Web of Science ®Google Scholar
• Mast N, Saadane A, Valencia-Olvera A, Constans J, Maxfield E, Arakawa H, Li Y, Landreth G, Pikuleva IA. 2017. Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer’s disease. Neuropharmacology. 123:465–476.
   PubMed Web of Science ®Google Scholar
• More VR, Campos CR, Evans RA, Oliver KD, Chan GN, Miller DS, Cannon RE. 2017. PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression. J Cereb Blood Flow Metab. 37:1199–1212.
   PubMed Web of Science ®Google Scholar
• Munetsuna E, Hojo Y, Hattori M, Ishii H, Kawato S, Ishida A, Kominami SA, Yamazaki T. 2009. Retinoic acid stimulates 17beta-estradiol and testosterone synthesis in rat hippocampal slice cultures. Endocrinology. 150:4260–4269.
   PubMed Web of Science ®Google Scholar
• Narang VS, Fraga C, Kumar N, Shen J, Throm S, Stewart CF, Waters CM. 2008. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. Am J Physiol Cell Physiol. 295:C440–C450.
   PubMed Web of Science ®Google Scholar
• Nickel S, Mahringer A. 2014. The xenoestrogens ethinylestradiol and bisphenol A regulate BCRP at the blood-brain barrier of rats. Xenobiotica. 44:1046–1054.
   PubMed Web of Science ®Google Scholar
• Pastor-Anglada M, Cano-Soldado P, Errasti-Murugarren E, Casado FJ. 2008. SLC28 genes and concentrative nucleoside transporter (CNT) proteins. Xenobiotica. 38:972–994.
   PubMed Web of Science ®Google Scholar
• Rezen T, Rozman D, Pascussi JM, Monostory K. 2011. Interplay between cholesterol and drug metabolism. Biochim Biophys Acta. 1814:146–160.
   PubMed Web of Science ®Google Scholar
• Roth M, Obaidat A, Hagenbuch B. 2012. OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol. 165:1260–1287.
   PubMed Web of Science ®Google Scholar
• Sakakibara Y, Katoh M, Imai K, Kondo Y, Asai Y, Ikushiro S, Nadai M. 2016. Expression of UGT1A subfamily in rat brain. Biopharm Drug Dispos. 37:314–319.
   PubMed Web of Science ®Google Scholar
• Singh A, Mudawal A, Maurya P, Jain R, Nair S, Shukla RK, Yadav S, Singh D, Khanna VK, Chaturvedi RK, et al. 2016. Prenatal exposure of cypermethrin induces similar alterations in xenobiotic-metabolizing cytochrome P450s and rate-limiting enzymes of neurotransmitter synthesis in brain regions of rat offsprings during postnatal development. Mol Neurobiol. 53:3670–3689.
   PubMed Web of Science ®Google Scholar
• Singh AK, Kashyap MP, Jahan S, Kumar V, Tripathi VK, Siddiqui MA, Yadav S, Khanna VK, Das V, Jain SK, Pant AB. 2012. Expression and inducibility of cytochrome P450s (CYP1A1, 2B6, 2E1, 3A4) in human cord blood CD34(+) stem cell-derived differentiating neuronal cells. Toxicol Sci. 129:392–410.
   PubMed Web of Science ®Google Scholar
• Sonoda J, Pei L, Evans RM. 2008. Nuclear receptors: decoding metabolic disease. FEBS Lett. 582:2–9.
   PubMed Web of Science ®Google Scholar
• Terwel D, Steffensen KR, Verghese PB, Kummer MP, Gustafsson JA, Holtzman DM, Heneka MT. 2011. Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosis. J Neurosci. 31:7049–7059.
   PubMed Web of Science ®Google Scholar
• Toselli F, de Waziers I, Dutheil M, Vincent M, Wilce PA, Dodd PR, Beaune P, Loriot MA, Gillam EM. 2015. Gene expression profiling of cytochromes P450, ABC transporters and their principal transcription factors in the amygdala and prefrontal cortex of alcoholics, smokers and drug-free controls by qRT-PCR. Xenobiotica. 45:1129–1137.
   PubMed Web of Science ®Google Scholar
• Tripathi VK, Kumar V, Pandey A, Vatsa P, Dhasmana A, Singh RP, Appikonda SHC, Hwang I, Lohani M. 2017. Monocrotophos induces the expression of xenobiotic metabolizing cytochrome P450s (CYP2C8 and CYP3A4) and neurotoxicity in human brain cells. Mol Neurobiol. 54:3633–3651.
   PubMed Web of Science ®Google Scholar
• Wang X, Sykes DB, Miller DS. 2010. Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier. Mol Pharmacol. 78:376–383.
   PubMed Web of Science ®Google Scholar
• Witusik-Perkowska M, Zakrzewska M, Sikorska B, Papierz W, Jaskolski DJ, Szemraj J, Liberski PP. 2017. Glioblastoma-derived cells in vitro unveil the spectrum of drug resistance capability - comparative study of tumour chemosensitivity in different culture systems. Biosci Rep. 37:BSR20170058.
   PubMed Web of Science ®Google Scholar
• Yu N, Zhang YF, Zhang K, Cheng YF, Ma HY, Di Q. 2017. Pregnane X receptor not nuclear factor-kappa B up-regulates P-glycoprotein expression in the brain of chronic epileptic rats induced by kainic acid. Neurochem Res. 42:2167–2177.
   PubMed Web of Science ®Google Scholar
• Zhang N, Wang Z, Zhou L. 2017. Aspirin resistance are associated with long-term recurrent stroke events after ischaemic stroke. Brain Res Bull. 134:205–210.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang J, Sun H, Zhu H, Liu H, Yang Y. 2013. An enriched environment elevates corticosteroid receptor levels in the hippocampus and restores cognitive function in a rat model of chronic cerebral hypoperfusion. Pharmacol Biochem Behav. 103:693–700.
   PubMed Web of Science ®Google Scholar